#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Comment to the article N. Dahmardeh et al. Fingolimod attenuates harmaline-induced passive avoidance memory and motor impairments in a rat model of essential tremor


Authors: Baoqiong Liu;  Md Md;  Phd
Authors place of work: Florida Hospital Medical Center ;  USA ;  Department of Internal Medicine
Published in the journal: Cesk Slov Neurol N 2018; 81(6): 699
Category: Komentář k článku

I have read, with great interest, the article entitled “Fingolimod attenuates harmaline-induced passive avoidance memory and motor impairments in a rat model of essential tremor”.

In this study, the authors constructed a harmaline-induced tremor model in rats, which has been extensively used as an animal model for essential tremor (ET) [1].Interestingly, the authors have also found that harmaline can cause cognitive disturb­ances by using passive avoidance test. Therefore, it is indeed an ideal model to study the effect of fingolimod on cognitive deficits associated with ET. The authors’ results demonstrated that pretreatment with fingolimod could ameliorate harmaline induced tremor, motor dysfunction as well as cognitive impairment, which is exciting. The authors should be congratulated for their laboratory findings on a topic not fully explored.

However, there are two main limitations noted in this article. Although the authors documented that fingolimod was admi­nistered (1 mg/kg) intraperitoneally 24 h before harmaline injection, it was not clear how the authors had decided the dosage. Using different doses would better determine the efficacy of fingolimod on ET-associated cognitive deficits. Another issue would be that tremor intensity, motor impairment and passive avoidance memory were evaluated at only one time point (30 min after harmaline injection). It would be of particular interest to know how long the positive effect of fingolimod on harmaline induced tremor and cognitive impairment would last. As shown in other articles, efficacy of specific treatments on harmaline induced tremor was tested at multiple time points [2,3].


Zdroje

1. Cheng MM, Tang G, Kuo SH. Harmaline-induced tremor in mice: videotape documentation and open questions about the model. Tremor Other Hyperkinet Mov (N Y) 2013; 3: pii. doi: 10.7916/D8H993W3.

2. Shourmasti FR, Goudarzi I, Abrari K et al. Riluzole ameliorates harmaline-induced tremor in rat. Basic Clin Neurosci 2014; 5(2): 138–143.

3. Nahab FB, Handforth A, Brown T et al. Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor. Neurotherapeutics 2012; 9(3): 635–638. doi: 10.1007/s13311-012-0121-1.

Štítky
Dětská neurologie Neurochirurgie Neurologie

Článek vyšel v časopise

Česká a slovenská neurologie a neurochirurgie

Číslo 6

2018 Číslo 6
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#